Exploiting antibodies as catalysts: Potential therapeutic applications

Transfusion Clinique et Biologique

Volumn 9, Issue 1, 2002, Pages 1-8

  Tellier, C ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Abzymes; Autoantibody; Catalytic antibodies; Therapeutic antibodies; Transition state analogue

Indexed keywords

AUTOANTIBODY; CATALYTIC ANTIBODY; COCAINE; IDIOTYPIC ANTIBODY; NERVE GAS; ORGANOPHOSPHATE INSECTICIDE;

ANIMAL MODEL; ANTIGEN BINDING; ASTHMA; AUTOIMMUNITY; CANCER CHEMOTHERAPY; CATALYSIS; COCAINE DEPENDENCE; CONFERENCE PAPER; DRUG INTOXICATION; HASHIMOTO DISEASE; IMMUNIZATION; IMMUNOTHERAPY; LUPUS ERYTHEMATOSUS; MOUSE; NONHUMAN; RAT;

EID: 0036182538     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(01)00208-7     Document Type: Conference Paper

References (44)

1. Selective chemical catalysis by an antibody
2. Chemical reactivity at an antibody binding site elicited by mechanistic design of a synthetic antigen
3. Critical analysis of antibody catalysis
4. Crystal structure of a catalytic antibody fab with Esterase-like activity
5. A comparison of the crystallographic structures of two catalytic antibodies with esterase activity
6. Transition state and multisubstrate analog inhibitors
7. Bait and switch strategy for obtaining catalytic antibodies with acyl-transfer capabilities
8. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis
9. Mechanism of an antibody-catalyzed allylic isomerization
10. Structural evidence for a programmed general base in the active site of a catalytic antibody
11. Immune versus natural selection: Antibody aldolases with enzymic rates but broader scope
12. Reactive immunization
13. Antibody catalysis of a Diels-Alder reaction
14. Antibody catalysis of pericyclic reactions
15. Immunological origins of binding and catalysis in a Diels-Alderase antibody
16. Abzyme generation using an anti-idiotypic antibody as the "internal image" of an enzyme active site
17. Enzyme mimicry by the anti-idiotypic antibody approach
18. Toward a network theory of the immune system
19. Anti-idiotypic antibodies exhibiting an acetylcholinesterase abzyme activity
20. Functional mimicry: Elicitation of a monoclonal anti-idiotypic antibody hydrolizing betalactams
21. Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies
22. Catalytic activity of anti-thyroglobulin antibodies
23. Natural catalytic antibodies: Peptide-hydrolyzing activities of bence jones proteins and V-L fragment
24. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain
25. Amidolytic and peptidolytic activities of immunoglobulin G present in sera from patients with rheumatoid arthritis, Sjögren's syndrome and systemic lupus erythematosus
26. Characterization of thyroglobulin-directed and polyreactive catalytic antibodies in autoimmune disease
27. Substrate specificity of serum DNA- and RNA-hydrolyzing antibodies of patients with polyarthritis and autoimmune thyroiditis
28. Overpassing an aberrant V(kappa) gene to sequence an anti-idiotypic abzyme with (beta)-lactamase-like activity that could have a linkage with autoimmune diseases
29. Improved generation of catalytic antibodies by MRL/MPJ-Ipr/Ipr autoimmune mice
30. Innate antibody catalysis
31. Reconstructing aldolase antibodies to alter their substrate specificity and turnover
32. Polyclonal antibody catalytic variability
33. Antibody-catalyzed degradation of cocaine
34. Generation of polyclonal catalytic antibodies against cocaine using transition state analogs of cocaine conjugated to diphtheria toxoid
35. A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats
36. A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: A dose and time course analysis
37. Towards catalytic antibodies for the degradation of toxic agents
38. Toward antibody-directed "abzyme" prodrug therapy, ADAPT: Carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing
39. Antibody directed enzyme prodrug therapy (ADEPT): A review of the experimental and clinical considerations
40. Multiple event activation of a generic prodrug trigger by antibody catalysis
41. In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy
42. Designed evolution of enzymatic properties